01—Abstract
Summary
Summary of the 8-K filed March 31, 2026. Cited figures are marked; the original filing is the authoritative source.
Labcorp Holdings Inc. (NYSE: LH) filed this Current Report on Form 8-K on March 31, 2026 under Item 7.01 (Regulation FD Disclosure) to announce the timing of its first-quarter 2026 financial results.
The company will release those results before the market opens on Thursday, April 30, 2026, and will host a conference call and webcast beginning at 9:00 a.m. ET that day to discuss them. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website, and a replay of the webcast will be available there approximately two hours after the live event, for one year.
The press release dated March 31, 2026 is furnished as Exhibit 99.1 and is incorporated by reference. The filing itself contains no financial results, guidance, or operating metrics.
Its substance is administrative: it sets the date and format for the company's Q1 2026 earnings disclosure. The Exhibit 99.1 announcement also describes Labcorp as a global laboratory services provider with nearly 71,000 employees serving clients in approximately 100 countries, and notes it performed more than 750 million tests for patients around the world.
02—Key points
Key Highlights
- Labcorp will report first-quarter 2026 financial results before market open on Thursday, April 30, 2026.
- A conference call and webcast will begin at 9:00 a.m. ET on April 30, 2026.
- Earnings release and accompanying financial information will be posted on the Labcorp Investor Relations website.
- A webcast replay will be available on the investor relations website about two hours after the live event, for one year.
- The filing is a Regulation FD disclosure (Item 7.01); the press release is furnished as Exhibit 99.1, not filed.
- The announcement describes Labcorp as serving clients in approximately 100 countries with nearly 71,000 employees.
- The company states it performed more than 750 million tests for patients worldwide and supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025.
03—Questions
Frequently Asked Questions
When will Labcorp report its first-quarter 2026 results?
Labcorp will release its first-quarter 2026 financial results before the market opens on Thursday, April 30, 2026.
How can investors access the earnings discussion?
The company will host a webcast beginning at 9:00 a.m. ET on April 30, 2026. A link will be available on the Labcorp Investor Relations website, and a replay will be posted there approximately two hours after the live event and available for one year.
Where will the earnings release be published?
The earnings press release and accompanying financial information will be posted in the 'News & Events' section of the Labcorp Investor Relations website.
Does this filing include the actual first-quarter results?
No. This 8-K only announces the timing and format of the release. The press release furnished as Exhibit 99.1 is an announcement of the release date and webcast details, and the filing does not itself report quarterly financial figures.
04—Continue